Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post‐hoc analysis of the ATHENA trial

AIMS: Limited therapeutic options are available for the management of atrial fibrillation/flutter (AF/AFL) with concomitant heart failure (HF) with preserved (HFpEF) and mildly reduced ejection fraction (HFmrEF). Dronedarone reduces the risk of cardiovascular events in patients with AF, but sparse d...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaduganathan, Muthiah, Piccini, Jonathan P., Camm, A. John, Crijns, Harry J.G.M., Anker, Stefan D., Butler, Javed, Stewart, John, Braceras, Rogelio, Albuquerque, Alessandro P.A., Wieloch, Mattias, Hohnloser, Stefan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2022
Materias:
Treatment of Comorbidities
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543163/
https://www.ncbi.nlm.nih.gov/pubmed/35293087
http://dx.doi.org/10.1002/ejhf.2487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543163/
https://www.ncbi.nlm.nih.gov/pubmed/35293087
http://dx.doi.org/10.1002/ejhf.2487

Ejemplares similares